Democratization of Genomic Medicine: Michael Bolick at TEDxGreenville The time has come for genomic medicine to prevail in the community-based healthcare delivery system. Continue reading
Tag Archives: genomic
Foundation Medicine and Memorial Sloan-Kettering Cancer Center Announce Partnership to Advance Patient Care in …
CAMBRIDGE, Mass. & NEW YORK–(BUSINESS WIRE)– Foundation Medicine and Memorial Sloan-Kettering Cancer Center today announced a partnership that brings together clinical, genomic and computational expertise to advance patient care in hematologic cancers. This effort will focus on co-development of a new Foundation Medicine molecular diagnostic product designed to match patients with hematologic cancers (leukemia, lymphoma or myeloma) with the most rational targeted therapies or clinical trials for their cancer Continue reading
New Book on Genome and Personalized Medicine Preps Doctors for Changing Reality
An all-new edition of Genomic and Personalized Medicine promises to be a one-stop shop for doctors and other health professionals as they face the rapid growth of genetic and genomic testing in the clinic. Continue reading
Veracyte Announces Study Results Published Online in New England Journal of Medicine Which Suggest that Its Afirma® …
HOUSTON, June 25, 2012 /PRNewswire/ –Veracyte, Inc., a molecular diagnostics company that is pioneering the emerging field of molecular cytology, today announced results from a large, prospective, multicenter study, which demonstrated the potential for the Afirma Gene Expression Classifier, a gene expression test, to reduce the large number of unnecessary surgeries in thyroid cancer diagnosis by more than half. (Logo: http://photos.prnewswire.com/prnh/20120625/SF29625LOGO) The results are being shared during a late-breaking data presentation at The Endocrine Society’s ENDO 2012: The 94th Annual Meeting & Expo in Houston, Texas, and coincide with online publication by the New England Journal of Medicine. The study is scheduled to appear in the journal’s August 23, 2012 print issue. Continue reading
Foundation Medicine Enters Extensive Collaboration to Provide Genomic Information for Clinical Oncology Programs
CAMBRIDGE, Mass.–(BUSINESS WIRE)– Foundation Medicine today announced a new agreement with Novartis to provide comprehensive genomic analysis in support of Novartis clinical oncology programs. Novartis plans to use Foundation Medicines molecular information platform across many of Novartis Phase 1 and 2 oncology clinical programs. Continue reading
Foundation Medicine Announces New Data Using Next-Generation Sequencing to Detect Cancer-Related Mutations Not …
CAMBRIDGE, Mass. & CHICAGO–(BUSINESS WIRE)– Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer genomic analysis to routine clinical care, today announced results from two studies using next-generation sequencing (NGS) to provide actionable information about genomic tumor alterations in individual patients cancers across all solid tumor types. The studies, being presented this week in an oral and poster session at the 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO), provide new evidence of the important role and clinical impact of NGS in cancer treatment. Continue reading
N-of-One Announces Agreement with Foundation Medicine to Provide the First Patient-Specific Genomic Diagnostic …
WALTHAM, Mass.–(BUSINESS WIRE)– N-of-One, Inc., provider of Diagnostic Strategy Roadmaps and Treatment Strategy Roadmaps for personalized cancer care, announced today that the company has entered into a strategic collaboration with Foundation Medicine, Inc. Continue reading
Clinical Sequencing at Medical College of Wisconsin – Howard Jacob – Video
12-12-2011 11:41 Genomic Medicine Centers Meeting II December 5-6, 2011 More: Continue reading